Outcome | Exposure | Mediator | Effect with mediator adjusted (95% CI) | Indirect effect by mediator (95% CI) | Mediation proportion (%) (95% CI) | P |
---|---|---|---|---|---|---|
Infectious diseases | SES | Lifestyle scores | 1.4895 (1.4646–1.5148) | 1.0008 (1.0008–1.0009) | 2.9 (2.6–3.3) |  < 0.001 |
CVD | 1.4815 (1.4610–1.5023) | 1.0018 (1.0016–1.0019) | 5.9 (5.5–6.3) |  < 0.001 | ||
Diabetes | 1.5081 (1.4873–1.5291) | 1.0006 (1.0005–1.0007) | 2.0 (1.8–2.2) |  < 0.001 | ||
Psychiatric disorders | 1.5338 (1.5127–1.5551) | 1.0002 (1.0002–1.0003) | 0.7 (0.6–0.8) |  < 0.001 | ||
Cancer | 1.5366 (1.5155–1.5580) | 1.0002 (1.0001–1.0002) | 0.6 (0.3–0.8) |  < 0.001 | ||
TDI | EPS group | 1.0708 (1.0673–1.0743) | 1.0002 (1.0000–1.0004) | 2.3 (0.3–4.3) | 0.014 | |
Respiratory infectious diseases | SES | Lifestyle scores | 1.4835 (1.3508–1.6302) | 1.0016 (1.0008–1.0024) | 4.1 (2.1–6.6) |  < 0.001 |
CVD | 1.4757 (1.3656–1.5953) | 1.0027 (1.0019–1.0037) | 6.8 (4.7–9.8) |  < 0.001 | ||
Diabetes | 1.5103 (1.3982–1.6321) | 1.0009 (1.0004–1.0014) | 2.2 (1.1–3.6) |  < 0.001 | ||
Psychiatric disorders | 1.5465 (1.4323–1.6706) | 1.0001 (0.9997–1.0004) | 0.2 (− 0.7–1.0) | 0.576 | ||
Cancer | 1.5485 (1.4339–1.6730) | 1.0001 (0.9993–1.0007) | 0.2 (− 1.7–1.7) | 0.804 | ||
TDI | EPS group | 1.0606 (1.0418–1.0797) | 1.0015 (1.0001–1.0028) | 12.7 (1.4–25.7) | 0.028 | |
Digestive infectious diseases | SES | Lifestyle scores | 1.4466 (1.3971–1.4979) | 1.0011 (1.0009–1.0013) | 2.9 (2.3–3.7) |  < 0.001 |
CVD | 1.4313 (1.3907–1.4732) | 1.0025 (1.0021–1.0028) | 6.4 (5.5–7.4) |  < 0.001 | ||
Diabetes | 1.4511 (1.4100–1.4936) | 1.0011 (1.0009–1.0013) | 2.7 (2.2–3.3) |  < 0.001 | ||
Psychiatric disorders | 1.4830 (1.4413–1.5261) | 1.0003 (1.0001–1.0005) | 0.7 (0.3–1.2) |  < 0.001 | ||
Cancer | 1.4851 (1.4433–1.5283) | 1.0002 (1.0000–1.0004) | 0.5 (0.1–1.0) | 0.018 | ||
TDI | EPS group | 1.0641 (1.0571–1.0711) | 0.9999 (0.9994–1.0003) | − 1.4 (− 6.2–3.1) | 0.584 | |
Blood or sexually transmitted infectious diseases | SES | Lifestyle scores | 2.4246 (2.0957–2.8124) | 1.0015 (1.0004–1.0027) | 3.3 (1.0–6.0) | 0.004 |
CVD | 2.3007 (2.0435–2.5945) | 1.0010 (1.0005–1.0017) | 2.0 (1.1–3.5) |  < 0.001 | ||
Diabetes | 2.3386 (2.0780–2.6363) | 1.0006 (1.0001–1.0012) | 1.1 (0.3–2.5) | 0.002 | ||
Psychiatric disorders | 2.3447 (2.0844–2.6422) | 1.0011 (1.0003–1.0020) | 2.2 (0.6–4.1) | 0.012 | ||
Cancer | 2.3866 (2.1208–2.6905) | 1.0005 (0.9996–1.0014) | 1.1 (− 0.8–2.9) | 0.242 | ||
TDI | EPS group | 1.1350 (1.1056–1.1654) | 0.9995 (0.9972–1.0018) | − 2.6 (− 14.5–9.2) | 0.642 | |
Infectious diseases in 2010 | SES | Lifestyle scores | 1.4439 (1.3864–1.5039) | 1.0005 (1.0004–1.0007) | 2.0 (1.5–2.8) |  < 0.001 |
CVD | 1.4129 (1.3657–1.4618) | 1.0019 (1.0016–1.0022) | 7.1 (6.1–8.4) |  < 0.001 | ||
Diabetes | 1.4400 (1.3920–1.4896) | 1.0006 (1.0005–1.0008) | 2.3 (1.8–2.9) |  < 0.001 | ||
Psychiatric disorders | 1.4642 (1.4157–1.5145) | 1.0002 (1.0002–1.0004) | 0.9 (0.6–1.3) |  < 0.001 | ||
Cancer | 1.4656 (1.4170–1.5161) | 1.0003 (1.0001–1.0005) | 1.0 (0.2–1.7) | 0.014 | ||
TDI | EPS group | 1.0617 (1.0531–1.0704) | 0.9999 (0.9995–1.0002) | − 1.5 (− 7.0–3.4) | 0.568 |